← Browse by Condition
Medical Condition
survival
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3, Phase 2, Phase 3
NCT04280822 Phase 3
Recruiting
Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma
Enrollment
400 pts
Location
China
Sponsor
Henan Cancer Hospital
NCT06563245 Phase 2, Phase 3
Recruiting
Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
Enrollment
96 pts
Location
China
Sponsor
Children's Cancer Group, China
NCT06627634
Recruiting
Radical Surgery for Advanced Gastric- or GEJ-cancer With Oligometastatic Dissmination to the Liver
Enrollment
20 pts
Location
Denmark
Sponsor
Aarhus University Hospital